For research use only
| Cat No. | ABC-TC0253 |
| Product Type | Human Uterine Cancer Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cervix |
| Disease | Cervix Cancer |
| Product Code | FL*; FL (HeLa derivative) |
Explore FL cell line from AcceGen, a human cervix carcinoma model extensively used for studies of virus susceptibility, tumorigenicity, and morphology.
FL cell line is a human cell line originally established from normal amniotic tissue obtained from a 30-year-old female donor. These cells exhibit characteristic epithelial morphology and demonstrate robust adherent growth properties in standard in vitro culture systems. Cytogenetic analysis confirms a well-characterized hypotriploid karyotype with a definitive modal chromosome number of 71. Immunohistochemical profiling via validated immunoperoxidase staining demonstrates consistent keratin expression. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | FL*; FL (HeLa derivative) |
| Species | Human |
| Cat.No | ABC-TC0253 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cervix |
| Disease | Cervix Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Uterine Cancer Cell Lines |
FL cells serve as a specialized in vitro model for studying HPV18-driven oncogenesis in cervical adenocarcinoma when engineered to harbor HPV18 oncogenic elements. For example, upon HPV18 modification, this cell system enables investigations into interactions between HPV18 viral oncoproteins and host cellular factors, elucidating key mechanisms underlying viral immune evasion, epithelial cell malignant transformation, and cervical adenocarcinoma progression. Such applications further support targeted drug screening against HPV18-associated malignancies and molecular pathology research, ultimately aiding the development of therapeutic strategies for HPV-driven cervical cancer.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
